St John of God Hospital, Subiaco

Subiaco 6008

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration Resistant Prostate Cancer, Metastatic HER2-positive Breast Cancer

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed